targeting chemokines in lymphoma
Published 6 years ago • 72 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:30
the use of targeted drug therapy for aggressive lymphoma
-
6:38
the sequencing of cd19-targeting car-ts and cd20-targeting bispecifics in dlbcl
-
2:25
using ctdna in lymphoma: recent advances and future directions
-
1:34
australasian lymphoma alliance consensus practice statement on the diagnosis and management of fl
-
0:51
treating patients with hodgkin lymphoma who are chemo-resistant
-
1:28
the remaining hurdles for using ctdna in lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
8:06
findings from arms 6 and 7 of the epcore nhl-2 trial: epcoritamab in newly diagnosed fl
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
2:02
targeting the survival cascade of b-cells in lymphoid malignancies
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
5:21
chemo-free regimens in lymphoma
-
1:14
promising novel agents in aml: menin inhibitors
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:59
updates on the use of nivolumab in hodgkin lymphoma & how this agent may impact treatment
-
1:44
updates in the who classification for lymphoma and how this may impact clinical practice